[ad_1] dentalcorp Holdings to make normal course issuer bid [ad_2] Source: Seekingalpha
Browsing: Healthcare
[ad_1] Bayer bets $547M on therapies for RNA-driven cancers [ad_2] Source: Seekingalpha
[ad_1] Gain slips after early-stage data for Parkinson’s therapy [ad_2] Source: Seekingalpha
[ad_1] American Diversified to cancel 142M shares [ad_2] Source: Seekingalpha
[ad_1] BioCardia shares climb as it gets FDA clearance for its Morph DNA product family [ad_2] Source: Seekingalpha
[ad_1] Nuvectis gains on FDA’s orphan drug designation for cancer therapy [ad_2] Source: Seekingalpha
[ad_1] Neurocrine upped to overweight by Piper, sees ‘568 as still viable [ad_2] Source: Seekingalpha
[ad_1] CooperCompanies hits 52-week high on Q3 beat and guidance [ad_2] Source: Seekingalpha
[ad_1] Lifecore CFO John Morberg to depart, Ryan Lake to succeed [ad_2] Source: Seekingalpha
[ad_1] J&J submits FDA application for myasthenia gravis drug nipocalimab [ad_2] Source: Seekingalpha
